Hanmi Pharm. Co., Ltd.

Hanmi Science Co., Ltd.

Hanmi Pharmaceutical Co., Ltd.

Eun Young Byun

Young Gil Ahn

In Hwan Bae

Ji Young Song

Ho Seok Kim

Seung Ah Jun

Kwee Hyun Suh

Jung Beom Son

Eun Joo Kwak

Seung Hyun Jung

Sang Mi Han

Maeng Sup Kim

Ji Sook Kim

Won Jeoung Kim

Young Hee Jung

Nam Du Kim

Moon Sub Lee

Mi Yon Shim

Hae Kyoung Ju

A novel imidazopyridine derivative compound and uses thereof are disclosed. An imidazopyridopyridine derivative compound of Chemical Formula 1 having selective inhibitory activity for a fibroblast growth factor receptor (FGFR) and a pharmaceutical composition including the compound are disclosed: 

Imidazopyridopyrimidine derivative compound and use thereof

Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.

Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases

Provided is a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate, and a solvate thereof, which is effective in the prevention and treatment of a cancer, inflammation, autoimmune diseases or neurodegenerative disorders which are induced by the overexpression of inhibitor of apoptosis proteins (IAPs).

Quinoline or quinazoline derivatives with apoptosis inducing activity on cells

Growing community of inventors

Hanam-si, South Korea

Eun Young Byun